Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

A unique mucin immunoenhancing peptide with antitumor properties.

A unique mucin immunoenhancing peptide with antitumor properties. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • A unique mucin immunoenhancing peptide with antitumor properties. Abstract Text:

    lynn m herbertLynn M Herbert,joseph f grossoJoseph F Grosso,mantley dorseyMantley Dorsey,tihui fuTihui Fu,iafa keydarIafa Keydar,mabel a cejasMabel A Cejas,daniel h wreschnerDaniel H Wreschner,nechama smorodinskiNechama Smorodinski,diana m lopezDiana M Lopez,

    Implantation of DA-3 mammary tumor cells into BALB/c mice results in tumor growth, metastatic lesions, and death. These cells were transfected with genes encoding for either the transmembrane (DA-3/TM) or secreted (DA-3/sec) form of human mucin 1 (MUC1). Although the gene for the secreted form lacks the transmembrane and cytoplasmic domains, the 5' sequences of these mucins are identical; however, the gene for the secreted mucin isoform ends with a sequence encoding for a unique 11 amino acid peptide. The DA-3/TM or DA-3 cells transfected with the neomycin vector only (DA-3/neo) have the same in vivo growth characteristics as the parent cell line. In contrast, DA-3/sec cells fail to grow when implanted in immunocompetent BALB/c animals. DA-3/sec cells implanted in nude mice resulted in tumor development verifying the tumorigenic potential of these cells. Pre-exposure of BALB/c mice to DA-3/sec cells afforded protection against challenge with DA-3/TM or DA-3/neo mammary tumors and the unrelated tumors K7, an osteosarcoma, and RENCA, a renal cell carcinoma. Partial protection against subsequent tumor challenges was also achieved by substituting the 11 amino acid peptide found only in the secreted MUC1 isoform, for the live DA-3/sec cells. Notably, the efficacy of this peptide is not strain restricted because it also retarded the growth of Lewis lung carcinoma cells in C57 BL/6 mice. These findings reveal that a unique peptide present in the secreted MUC1 has immunoenhancing properties and may be a potential agent for use in immunotherapy.

    A unique mucin immunoenhancing peptide with antitumor properties. Publishing Authors By Initials

    lm herbertLM Herbert,jf grossoJF Grosso,m dorseyM Dorsey,t fuT Fu,i keydarI Keydar,ma cejasMA Cejas,dh wreschnerDH Wreschner,n smorodinskiN Smorodinski,dm lopezDM Lopez,

    For similar peptides: peptide fragments research abstracts see: peptides: peptide fragments research

    PUBMED ID PMID:

    MEDLINE DATE:

    A unique mucin immunoenhancing peptide with antitumor properties. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Cancer research

    VOLUME: 64

    Page Numbers: 8077-84

    Journal Abbreviation: Cancer Res.

    ISSN: 0008-5472

    DAY: 1

    MONTH: Nov

    YEAR: 2004

    A unique mucin immunoenhancing peptide with antitumor properties. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 2984705

    A unique mucin immunoenhancing peptide with antitumor properties. Keywords Mesh Terms:

    KEYWORDS: Peptide Fragments

    MESH TERMS: physiology

    Chemical & Substance for Abstract: A unique mucin immunoenhancing peptide with antitumor properties. Information

    Substance Name: Peptide Fragments

    Registry Number: 0

    Grant and Affiliation Information for A unique mucin immunoenhancing peptide with antitumor properties.

    AFFILIATION: Department of Microbiology & Immunology, University of Miami School of Medicine, Miami, Florida 33101, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: R01 CA25583

    ACRONYM: CA

    MEDLINETA: Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    A unique mucin immunoenhancing peptide with antitumor properties Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News